{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T15:07:35Z","timestamp":1790262455964,"version":"4.1.0"},"reference-count":141,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,9,3]],"date-time":"2020-09-03T00:00:00Z","timestamp":1599091200000},"content-version":"vor","delay-in-days":2347,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Actas Dermo-Sifiliogr\u00e1ficas (English Edition)"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1016\/j.adengl.2012.10.021","type":"journal-article","created":{"date-parts":[[2014,3,21]],"date-time":"2014-03-21T06:00:54Z","timestamp":1395381654000},"page":"243-252","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Antimalarials in Dermatology: Mechanism of Action, Indications, and Side Effects"],"prefix":"10.1016","volume":"105","author":[{"given":"C.","family":"Rodriguez-Caruncho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Bielsa Marsol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.adengl.2012.10.021_bib0005","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1177\/0961203396005001021","article-title":"The history of antimalarials","volume":"5","author":"Wallace","year":"1996","journal-title":"Lupus"},{"key":"10.1016\/j.adengl.2012.10.021_bib0010","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0733-8635(05)70236-9","article-title":"Antimalarials","volume":"19","author":"Van Beek","year":"2001","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.adengl.2012.10.021_bib0015","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/S0140-6736(51)91643-1","article-title":"Treatment of lupus erythematosus with mepacrine","volume":"2","author":"Page","year":"1951","journal-title":"Lancet"},{"key":"10.1016\/j.adengl.2012.10.021_bib0020","doi-asserted-by":"crossref","first-page":"257","DOI":"10.2165\/00003088-199631040-00003","article-title":"Clinical pharmacokinetics and metabolism of chloroquine. Focus on recent advancements","volume":"3","author":"Ducharme","year":"1996","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.adengl.2012.10.021_bib0025","doi-asserted-by":"crossref","first-page":"263","DOI":"10.2165\/00003088-199630040-00002","article-title":"Pharmacokinetics of quinine, chloroquine and amodiaquine. Clinical implications","volume":"30","author":"Krishna","year":"1996","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.adengl.2012.10.021_bib0030","doi-asserted-by":"crossref","first-page":"426","DOI":"10.2340\/0001555573426429","article-title":"Chloroquine phosphate: a long-term follow-up of drug concentrations in skin suction blister fluid and plasma","volume":"73","author":"Sj\u00f6lin-Forsberg","year":"1993","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.adengl.2012.10.021_bib0035","doi-asserted-by":"crossref","first-page":"3207","DOI":"10.1002\/art.11304","article-title":"Safety of hydroxychloroquine in pregnant patients with connective tissue diseases: a study of one hundred thirty-three cases compared with a control group","volume":"48","author":"Costedoat-Chalumeau","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.adengl.2012.10.021_bib0040","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1002\/jps.20792","article-title":"Lysosomal sequestration of amine-containing drugs: analysis and therapeutic implications","volume":"96","author":"Kaufmann","year":"2007","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.adengl.2012.10.021_bib0045","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/0006-2952(74)90174-9","article-title":"Commentary. Lysosomotropic agents","volume":"23","author":"De Duve","year":"1974","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.adengl.2012.10.021_bib0050","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/j.1529-8019.2007.00131.x","article-title":"New concepts in antimalarial use and mode of action in dermatology","volume":"20","author":"Kalia","year":"2007","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.adengl.2012.10.021_bib0055","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1191\/0961203302lu147rr","article-title":"Antimalarials in cutaneous lupus erythematosus: mechanisms of therapeutic benefit","volume":"11","author":"Wozniacka","year":"2002","journal-title":"Lupus"},{"key":"10.1016\/j.adengl.2012.10.021_bib0060","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/S0049-0172(10)80012-5","article-title":"Mechanism of action of hydroxychloroquine as an antirheumatic drug","volume":"23","author":"Fox","year":"1993","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.adengl.2012.10.021_bib0065","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1177\/0961203396005001031","article-title":"Anti-malarial drugs: possible mechanisms of action in autoimmune disease and prospects for drug development","volume":"5","author":"Fox","year":"1996","journal-title":"Lupus"},{"key":"10.1016\/j.adengl.2012.10.021_bib0070","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/S1699-258X(06)73045-5","article-title":"Antipal\u00fadicos: actualizaci\u00f3n de su uso en enfermedades reum\u00e1ticas","volume":"2","author":"Jim\u00e9nez","year":"2006","journal-title":"Reumatol Clin"},{"key":"10.1016\/j.adengl.2012.10.021_bib0075","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1093\/rheumatology\/36.7.799","article-title":"Antimalarial drugs in the treatment of rheumatological diseases","volume":"36","author":"Rynes","year":"1997","journal-title":"Br J Rheumatol"},{"key":"10.1016\/j.adengl.2012.10.021_bib0080","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S0306-3623(97)00269-3","article-title":"Antimalarial drugs inhibit phospholipase A2 activation and induction of interleukin 1beta and tumor necrosis factor alpha in macrophages: implications for their mode of action in rheumatoid arthritis","volume":"30","author":"Bondeson","year":"1998","journal-title":"Gen Pharmacol"},{"key":"10.1016\/j.adengl.2012.10.021_bib0085","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/S0213-9251(03)72770-1","article-title":"Uso de los antimal\u00e1ricos en dermatolog\u00eda","volume":"18","author":"Bielsa","year":"2003","journal-title":"Piel"},{"key":"10.1016\/j.adengl.2012.10.021_bib0090","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0738-081X(99)00092-9","article-title":"Antimalarials: unapproved uses or indications","volume":"18","author":"Wolf","year":"2000","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.adengl.2012.10.021_bib0095","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1191\/096120398678919912","article-title":"4-Aminoquinoline antimalarials enhance UV-B induced c-jun transcriptional activation","volume":"7","author":"Nguyen","year":"1998","journal-title":"Lupus"},{"key":"10.1016\/j.adengl.2012.10.021_bib0100","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1001\/jama.1960.03020150054010","article-title":"Use of antimalarial drugs as desludging agents in vascular disease processes","volume":"172","author":"Madow","year":"1960","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.adengl.2012.10.021_bib0105","first-page":"143","article-title":"Antiaggregation action of chloroquine","volume":"50","author":"Bertrand","year":"1990","journal-title":"Med Trop (Mars)"},{"key":"10.1016\/j.adengl.2012.10.021_bib0110","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1055\/s-0038-1650183","article-title":"The effect of phospholipase inhibitor mepacrine on platelet aggregation, the platelet release reaction and fibrinogen binding to the platelet surface","volume":"45","author":"Winocour","year":"1981","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.adengl.2012.10.021_bib0115","first-page":"48","article-title":"Modification of transoperative changes in blood fluidity by hydroxychloroquine: a possible explanation for the drug's antithrombotic effect","volume":"4","author":"Ernst","year":"1984","journal-title":"Pharmatherapeutica"},{"key":"10.1016\/j.adengl.2012.10.021_bib0120","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1055\/s-0037-1613033","article-title":"Hydroxychloroquine reverses platelet activation induced by human IgG antiphospholipid antibodies","volume":"87","author":"Espinola","year":"2002","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.adengl.2012.10.021_bib0125","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/0049-3848(95)00028-3","article-title":"Chloroquine inhibits stimulated platelets at the arachidonic acid pathway","volume":"77","author":"Nos\u00e1l","year":"1995","journal-title":"Thromb Res"},{"key":"10.1016\/j.adengl.2012.10.021_bib0130","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1136\/ard.2008.101766","article-title":"Clinical efficacy and side effects of antimalarials in systemic lupus erythematosus: a systematic review","volume":"69","author":"Ruiz-Irastorza","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.adengl.2012.10.021_bib0135","first-page":"761","article-title":"Hydroxychloroquine sulfate in prevention of thromboembolic phenomena in surgical patients","volume":"41","author":"Pilcher","year":"1975","journal-title":"Am Surg"},{"key":"10.1016\/j.adengl.2012.10.021_bib0140","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/0002-9343(88)90364-6","article-title":"Hydroxychloroquine and postoperative thromboembolism after total hip replacement","volume":"85","author":"Loudon","year":"1988","journal-title":"Am J Med"},{"key":"10.1016\/j.adengl.2012.10.021_bib0145","first-page":"89","article-title":"Clinical and experimental evaluation of the thromboprophylactic effect of hydroxychloroquine sulfate after total hip replacement","volume":"10","author":"Johansson","year":"1981","journal-title":"Haemostasis"},{"key":"10.1016\/j.adengl.2012.10.021_bib0150","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1002\/art.1780301219","article-title":"Does hydroxychloroquine sulfate prevent clot formation in systemic lupus erythematosus","volume":"30","author":"Wallace","year":"1987","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.adengl.2012.10.021_bib0155","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1093\/rheumatology\/41.8.924","article-title":"A cross-sectional study of clinical thrombotic risk factors and preventive treatments in antiphospholipid syndrome","volume":"41","author":"Erkan","year":"2002","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.adengl.2012.10.021_bib0160","doi-asserted-by":"crossref","first-page":"3947","DOI":"10.1002\/art.20622","article-title":"Systemic lupus erythematosus in a multiethnic US cohort (LUMINA). XXIII. Baseline predictors of vascular events","volume":"50","author":"Toloza","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.adengl.2012.10.021_bib0165","doi-asserted-by":"crossref","first-page":"2774","DOI":"10.1002\/art.21224","article-title":"Incidence and risk factors of thromboembolism in systemic lupus erythematosus: a comparison of three ethnic groups","volume":"52","author":"Mok","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.adengl.2012.10.021_bib0170","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1093\/rheumatology\/kei014","article-title":"Systemic lupus erythematosus in a multiethnic cohort (LUMINA): XXVIII. Factors predictive of thrombotic events","volume":"44","author":"Ho","year":"2005","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.adengl.2012.10.021_bib0175","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1177\/0961203306069972","article-title":"Traditional and non-traditional risk factors contribute to the development of accelerated atherosclerosis in patients with systemic lupus erythematosus","volume":"15","author":"De Leeuw","year":"2006","journal-title":"Lupus"},{"key":"10.1016\/j.adengl.2012.10.021_bib0180","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1177\/0961203306071872","article-title":"Effect of antimalarials on thrombosis and survival in patients with systemic lupus erythematosus","volume":"15","author":"Ruiz-Irastorza","year":"2006","journal-title":"Lupus"},{"key":"10.1016\/j.adengl.2012.10.021_bib0185","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/md.0b013e318123f888","article-title":"Risk and predictors of arterial thrombosis in lupus and non-lupus primary glomerulonephritis: a comparative study","volume":"86","author":"Mok","year":"2007","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.adengl.2012.10.021_bib0190","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1002\/art.27289","article-title":"The protective effect of antimalarial drugs on thrombovascular events in systemic lupus erythematosus","volume":"62","author":"Jung","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.adengl.2012.10.021_bib0195","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1177\/09612033070160040901","article-title":"Chloroquine increases low-density lipoprotein removal from plasma in systemic lupus patients","volume":"16","author":"Sachet","year":"2007","journal-title":"Lupus"},{"key":"10.1016\/j.adengl.2012.10.021_bib0200","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s00296-002-0266-z","article-title":"Polymorphism of the beta3-adrenergic receptor and lipid profile in patients with rheumatoid arthritis and systemic lupus erythematosus treated with chloroquine","volume":"23","author":"Mu\u00f1oz-Valle","year":"2003","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.adengl.2012.10.021_bib0205","first-page":"780","article-title":"Longterm beneficial effect of chloroquine diphosphate on lipoprotein profile in lupus patients with and without steroid therapy","volume":"28","author":"Borba","year":"2001","journal-title":"J Rheumatol"},{"key":"10.1016\/j.adengl.2012.10.021_bib0210","first-page":"2142","article-title":"Effect of antimalarial agents on the fasting lipid profile in systemic lupus erythematosus","volume":"27","author":"Tam","year":"2000","journal-title":"J Rheumatol"},{"key":"10.1016\/j.adengl.2012.10.021_bib0215","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1191\/096120300678828541","article-title":"Hydroxychloroquine has no significant effect on lipids and apolipoproteins in Chinese systemic lupus erythematosus patients with mild or inactive disease","volume":"9","author":"Tam","year":"2000","journal-title":"Lupus"},{"key":"10.1016\/j.adengl.2012.10.021_bib0220","first-page":"661","article-title":"The lipid, lipoprotein, and apolipoprotein effects of hydroxychloroquine in patients with systemic lupus erythematosus","volume":"20","author":"Hodis","year":"1993","journal-title":"J Rheumatol"},{"key":"10.1016\/j.adengl.2012.10.021_bib0225","first-page":"325","article-title":"The cholesterol lowering effect of antimalarial drugs is enhanced in patients with lupus taking corticosteroid drugs","volume":"26","author":"Rahman","year":"1999","journal-title":"J Rheumatol"},{"key":"10.1016\/j.adengl.2012.10.021_bib0230","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/0002-9343(94)90151-1","article-title":"Effect of prednisone and hydroxychloroquine on coronary artery disease risk factors in systemic lupus erythematosus: a longitudinal data analysis","volume":"96","author":"Petri","year":"1994","journal-title":"Am J Med"},{"key":"10.1016\/j.adengl.2012.10.021_bib0235","doi-asserted-by":"crossref","unstructured":"Svenungsson E, Gunnarsson I, Fei GZ, Lundberg IE, Klareskog L, Frosteg\u00e5rd J. Elevated triglycerides and low levels of high-density lipoprotein as markers of disease activity in association with up-regulation of the tumor necrosis factor alpha\/tumor necrosis factor receptor system in systemic lupus erythematosus. Arthritis Rheum. 2003;48:2533-40.","DOI":"10.1002\/art.11264"},{"key":"10.1016\/j.adengl.2012.10.021_bib0240","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1177\/0961203396005001051","article-title":"Hydroxychloroquine use in the Baltimore Lupus Cohort: effects on lipids, glucose and thrombosis","volume":"5","author":"Petri","year":"1996","journal-title":"Lupus"},{"key":"10.1016\/j.adengl.2012.10.021_bib0245","doi-asserted-by":"crossref","first-page":"3569","DOI":"10.1002\/art.27703","article-title":"Changes in glycosylated hemoglobin after initiation of hydroxychloroquine or methotrexate treatment in diabetes patients with rheumatic diseases","volume":"62","author":"Rekedal","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.adengl.2012.10.021_bib0250","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.3899\/jrheum.090994","article-title":"Hydroxychloroquine and glycemia in women with rheumatoid arthritis and systemic lupus erythematosus","volume":"37","author":"Penn","year":"2010","journal-title":"J Rheumatol"},{"key":"10.1016\/j.adengl.2012.10.021_bib0255","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1191\/0961203305lu2039oa","article-title":"Bone mineral density in postmenopausal Chinese patients with systemic lupus erythematosus","volume":"14","author":"Mok","year":"2005","journal-title":"Lupus"},{"key":"10.1016\/j.adengl.2012.10.021_bib0260","first-page":"102","article-title":"Factors associated with low bone mineral density in female patients with systemic lupus erythematosus","volume":"28","author":"Lakshminarayanan","year":"2001","journal-title":"J Rheumatol"},{"key":"10.1016\/j.adengl.2012.10.021_bib0265","first-page":"829","article-title":"Use of antimalarials in dermatology","volume":"8","author":"Ochsendorf","year":"2010","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1016\/j.adengl.2012.10.021_bib0270","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1001\/archderm.1982.01650180046015","article-title":"Chronic cutaneous lupus erythematosus. Clinical, laboratory, therapeutic, and prognostic examination of 62 patients","volume":"118","author":"Callen","year":"1982","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.adengl.2012.10.021_bib0275","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1111\/j.1365-4362.1990.tb03464.x","article-title":"Treatment of subacute cutaneous lupus erythematosus","volume":"29","author":"Furner","year":"1990","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.adengl.2012.10.021_bib0280","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1038\/jid.2011.167","article-title":"Clinical and pharmacogenetic influences on response to hydroxychloroquine in discoid lupus erythematosus: a retrospective cohort study","volume":"131","author":"Wahie","year":"2011","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.adengl.2012.10.021_bib0285","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1001\/archdermatol.2008.592","article-title":"Lupus erythematosus tumidus: response to antimalarial treatment in 36 patients with emphasis on smoking","volume":"145","author":"Kreuter","year":"2009","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.adengl.2012.10.021_bib0290","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1056\/NEJM199101173240303","article-title":"A randomized study of the effect of withdrawing hydroxychloroquine sulfate in systemic lupus erythematosus","volume":"324","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.adengl.2012.10.021_bib0295","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1191\/096120398678919778","article-title":"A long-term study of hydroxychloroquine withdrawal on exacerbations in systemic lupus erythematosus. The Canadian Hydroxychloroquine Study Group","volume":"7","author":"Tsakonas","year":"1998","journal-title":"Lupus"},{"key":"10.1016\/j.adengl.2012.10.021_bib0300","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1001\/archdermatol.2011.191","article-title":"Response to antimalarial agents in cutaneous lupus erythematosus: a prospective analysis","volume":"147","author":"Chang","year":"2011","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.adengl.2012.10.021_bib0305","first-page":"1716","article-title":"Smoking interferes with efficacy of antimalarial therapy in cutaneous lupus","volume":"25","author":"Rahman","year":"1998","journal-title":"J Rheumatol"},{"key":"10.1016\/j.adengl.2012.10.021_bib0310","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1067\/mjd.2000.103635","article-title":"Patients with cutaneous lupus erythematosus who smoke are less responsive to antimalarial treatment","volume":"42","author":"Jewell","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.adengl.2012.10.021_bib0315","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1001\/archdermatol.2011.342","article-title":"Impact of smoking in cutaneous lupus erythematosus","volume":"148","author":"Piette","year":"2012","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.adengl.2012.10.021_bib0320","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1001\/archderm.1980.01640340057016","article-title":"Hydroxychloroquine treatment of porphyria cutanea tarda","volume":"116","author":"Malkinson","year":"1980","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.adengl.2012.10.021_bib0325","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/j.1365-2133.1984.tb06632.x","article-title":"Low-dose oral chloroquine in the treatment of porphyria cutanea tarda","volume":"111","author":"Ashton","year":"1984","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.adengl.2012.10.021_bib0330","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/0190-9622(92)70090-3","article-title":"High-dose hydroxychloroquine treatment of porphyria cutanea tarda","volume":"26","author":"Petersen","year":"1992","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.adengl.2012.10.021_bib0335","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0923-1811(94)90092-2","article-title":"Low-dose oral chloroquine in patients with porphyria cutanea tarda and low-moderate iron overload","volume":"7","author":"Valls","year":"1994","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.adengl.2012.10.021_bib0340","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1365-2133.1977.tb15431.x","article-title":"Treatment of porphyria cutanea tarda with chloroquine and phlebotomy","volume":"97","author":"Swanbeck","year":"1977","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.adengl.2012.10.021_bib0345","first-page":"119","article-title":"Chloroquine in treatment of porphyria cutanea tarda. Long-term efficacy of combined phlebotomy and high-dose chloroquine therapy","volume":"100","author":"Wennersten","year":"1982","journal-title":"Acta Derm Venereol Suppl (Stockh)"},{"key":"10.1016\/j.adengl.2012.10.021_bib0350","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0190-9622(90)70027-F","article-title":"Chronic ulcerative stomatitis associated with a specific immunologic marker","volume":"22","author":"Jaremko","year":"1990","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.adengl.2012.10.021_bib0355","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1111\/1523-1747.ep12876269","article-title":"Patients with erosive lichen planus may have antibodies directed to a nuclear antigen of epithelial cells: a study on the antigen nature","volume":"94","author":"Parodi","year":"1990","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.adengl.2012.10.021_bib0360","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/j.1365-4362.1996.tb03000.x","article-title":"Chronic ulcerative stomatitis with stratified epithelium-specific antinuclear antibodies","volume":"35","author":"Lewis","year":"1996","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.adengl.2012.10.021_bib0365","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.tripleo.2010.12.020","article-title":"Chronic ulcerative stomatitis: evidence of autoimmune pathogenesis","volume":"111","author":"Carlson","year":"2011","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"10.1016\/j.adengl.2012.10.021_bib0370","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1177\/154405910708600904","article-title":"Autoimmunity to deltaNp63alpha in chronic ulcerative stomatitis","volume":"86","author":"Solomon","year":"2007","journal-title":"J Dent Res"},{"key":"10.1016\/j.adengl.2012.10.021_bib0375","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1046\/j.1523-1747.1999.00651.x","article-title":"Characterization of an autoantigen associated with chronic ulcerative stomatitis: the CUSP autoantigen is a member of the p53 family","volume":"113","author":"Lee","year":"1999","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.adengl.2012.10.021_bib0380","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/S0190-9622(84)80263-7","article-title":"Cutaneous lesions of dermatomyositis are improved by hydroxychloroquine","volume":"10","author":"Woo","year":"1984","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.adengl.2012.10.021_bib0385","doi-asserted-by":"crossref","first-page":"341","DOI":"10.2165\/00128071-200607060-00002","article-title":"Management of cutaneous dermatomyositis: current therapeutic options","volume":"7","author":"Quain","year":"2006","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.adengl.2012.10.021_bib0390","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1001\/archderm.1995.01690240035006","article-title":"Dermatomyositis without muscle weakness. Long-term follow-up of 12 patients without systemic corticosteroids","volume":"131","author":"Cosnes","year":"1995","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.adengl.2012.10.021_bib0395","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1001\/archderm.141.7.855","article-title":"Combination antimalarials in the treatment of cutaneous dermatomyositis: a retrospective study","volume":"141","author":"Ang","year":"2005","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.adengl.2012.10.021_bib0400","first-page":"1016","article-title":"Amyopathic dermatomyositis, photosensitivity and hydroxychloroquine","volume":"132","author":"Cox","year":"1995","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.adengl.2012.10.021_bib0405","first-page":"1545","article-title":"Adjunctive use of hydroxychloroquine in childhood dermatomyositis","volume":"16","author":"Olson","year":"1989","journal-title":"J Rheumatol"},{"key":"10.1016\/j.adengl.2012.10.021_bib0410","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1001\/archderm.138.9.1231","article-title":"Adverse cutaneous reactions to hydroxychloroquine are more common in patients with dermatomyositis than in patients with cutaneous lupus erythematosus","volume":"138","author":"Pelle","year":"2002","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.adengl.2012.10.021_bib0415","first-page":"640","article-title":"Sarcoidosis apparently cured by quinacrine (Atabrine) hydrochloride","volume":"67","author":"Shaffer","year":"1953","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.adengl.2012.10.021_bib0420","first-page":"351","article-title":"Micropapular cutaneous sarcoidosis: case series successfully managed with hydroxychloroquine sulfate","volume":"81","author":"Modi","year":"2008","journal-title":"Cutis"},{"key":"10.1016\/j.adengl.2012.10.021_bib0425","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/0190-9622(90)70246-E","article-title":"Hydroxychloroquine is effective therapy for control of cutaneous sarcoidal granulomas","volume":"23","author":"Jones","year":"1990","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.adengl.2012.10.021_bib0430","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1007\/s00105-010-2120-7","article-title":"Uncommon cutaneous ulcerative and systemic sarcoidosis. Successful treatment with hydroxychloroquine and compression therapy","volume":"62","author":"Meyersburg","year":"2011","journal-title":"Hautarzt"},{"key":"10.1016\/j.adengl.2012.10.021_bib0435","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/S0140-6736(68)90225-0","article-title":"Chloroquine in pulmonary sarcoidosis","volume":"1","author":"Brodthagen","year":"1968","journal-title":"Lancet"},{"key":"10.1016\/j.adengl.2012.10.021_bib0440","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/S0007-0971(63)80005-4","article-title":"Sarcoidosis treated with chloroquine","volume":"57","author":"Davies","year":"1963","journal-title":"Br J Dis Chest"},{"key":"10.1016\/j.adengl.2012.10.021_bib0445","first-page":"257","article-title":"Chloroquine in the treatment of sarcoidosis. A report from the Research Committee of the British Tuberculosis Association","volume":"48","year":"1967","journal-title":"Tubercle"},{"key":"10.1016\/j.adengl.2012.10.021_bib0450","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1001\/archneur.55.9.1248","article-title":"Effectiveness of chloroquine and hydroxychloroquine in treating selected patients with sarcoidosis with neurological involvement","volume":"55","author":"Sharma","year":"1998","journal-title":"Arch Neurol"},{"key":"10.1016\/j.adengl.2012.10.021_bib0455","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3109\/01676830.2010.524268","article-title":"Orbital sarcoidosis treated with hydroxychloroquine","volume":"30","author":"Rabinowitz","year":"2011","journal-title":"Orbit"},{"key":"10.1016\/j.adengl.2012.10.021_bib0460","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/0002-9343(87)90237-3","article-title":"Hydroxychloroquine treatment of hypercalcemia in a patient with sarcoidosis undergoing hemodialysis","volume":"82","author":"Barr\u00e9","year":"1987","journal-title":"Am J Med"},{"key":"10.1016\/j.adengl.2012.10.021_bib0465","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1136\/pgmj.74.869.172","article-title":"Sarcoidosis of the paranasal sinuses treated with hydroxychloroquine","volume":"74","author":"Hassid","year":"1998","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.adengl.2012.10.021_bib0470","first-page":"1066","article-title":"Favourable course of a pseudotumoral form of hepatic and splenic sarcoidosis under treatment with hydroxychloroquine and colchicine","volume":"19","author":"Joundy","year":"1995","journal-title":"Gastroenterol Clin Biol"},{"key":"10.1016\/j.adengl.2012.10.021_bib0475","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/jid.1956.29","article-title":"Polymorphous light eruption; the effect of chloroquine phosphate in modifying reactions to ultra-violet light","volume":"26","author":"Cahn","year":"1956","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.adengl.2012.10.021_bib0480","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1001\/archderm.1967.01610010007001","article-title":"Immunologic concepts of light reactions in lupus erythematosus and polymorphous light eruptions. I. The mechanism of action of hydroxychloroquine","volume":"96","author":"Lester","year":"1967","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.adengl.2012.10.021_bib0485","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/j.1365-2133.1956.tb13207.x","article-title":"The treatment of polymorphic light eruptions with chloroquine","volume":"68","author":"Christiansen","year":"1956","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.adengl.2012.10.021_bib0490","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1111\/j.1365-2133.1982.tb00409.x","article-title":"Controlled therapeutic trials in polymorphic light eruption","volume":"107","author":"Corbett","year":"1982","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.adengl.2012.10.021_bib0495","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/j.1365-2133.1987.tb05852.x","article-title":"Hydroxychloroquine in polymorphic light eruption: a controlled trial with drug and visual sensitivity monitoring","volume":"116","author":"Murphy","year":"1987","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.adengl.2012.10.021_bib0500","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/S0190-9622(09)80089-3","article-title":"Antimalarials for control of disseminated granuloma annulare in children","volume":"31","author":"Simon","year":"1994","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.adengl.2012.10.021_bib0505","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1159\/000086452","article-title":"Treatment of generalized granuloma annulare with hydroxychloroquine","volume":"211","author":"Cannistraci","year":"2005","journal-title":"Dermatology"},{"key":"10.1016\/j.adengl.2012.10.021_bib0510","first-page":"125","article-title":"Beneficial effects of antimalarials in the treatment of generalized granuloma annular in children","volume":"84","author":"Masmoudi","year":"2006","journal-title":"Tunis Med"},{"key":"10.1016\/j.adengl.2012.10.021_bib0515","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/0190-9622(93)70082-5","article-title":"Hydroxychloroquine sulfate (Plaquenil) improves oral lichen planus: An open trial","volume":"28","author":"Eisen","year":"1993","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.adengl.2012.10.021_bib0520","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1111\/j.1365-4362.1994.tb02927.x","article-title":"Lichen planus subtropicus: direct immunofluorescence findings and therapeutic response to hydroxychloroquine","volume":"33","author":"Albers","year":"1994","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.adengl.2012.10.021_bib0525","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.jaad.2009.08.054","article-title":"Hydroxychloroquine and lichen planopilaris: efficacy and introduction of Lichen Planopilaris Activity Index scoring system","volume":"62","author":"Chiang","year":"2010","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.adengl.2012.10.021_bib0530","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1111\/j.1365-2133.2010.09965.x","article-title":"Frontal fibrosing alopecia: a clinical review of 36 patients","volume":"163","author":"Samrao","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.adengl.2012.10.021_bib0535","doi-asserted-by":"crossref","first-page":"S34","DOI":"10.1067\/mjd.2002.104969","article-title":"Necrobiosis lipoidica diabeticorum treated with chloroquine","volume":"46","author":"Nguyen","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.adengl.2012.10.021_bib0540","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1111\/j.1365-4632.2004.01735.x","article-title":"Papular elastolytic giant cell granuloma responding to hydroxychloroquine and quinacrine","volume":"43","author":"Kelly","year":"2004","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.adengl.2012.10.021_bib0545","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1001\/archderm.1994.01690100068011","article-title":"Chronic actinic dermatitis. An analysis of 51 patients evaluated in the United States and Japan","volume":"130","author":"Lim","year":"1994","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.adengl.2012.10.021_bib0550","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/S0190-9622(84)80308-4","article-title":"Actinic reticuloid. Response to combination treatment with azathioprine, hydroxychloroquine, and prednisone","volume":"10","author":"Haynes","year":"1984","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.adengl.2012.10.021_bib0555","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/S0190-9622(08)81962-7","article-title":"Antimalarials for children","volume":"30","author":"Maga\u00f1a-Garc\u00eda","year":"1994","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.adengl.2012.10.021_bib0560","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1001\/archderm.1963.01590200023004","article-title":"Solar urticaria","volume":"88","author":"Epstein","year":"1963","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.adengl.2012.10.021_bib0565","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1111\/j.1365-2230.1994.tb01208.x","article-title":"Extensive lichen sclerosus et atrophicus with bullae and ulceration\u2014improvement with hydroxychloroquine","volume":"19","author":"Wakelin","year":"1994","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.adengl.2012.10.021_bib0570","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0049-0172(88)90008-X","article-title":"Eosinophilic fasciitis: clinical spectrum and therapeutic response in 52 cases","volume":"17","author":"Lakhanpal","year":"1988","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.adengl.2012.10.021_bib0575","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1001\/archderm.1961.01580150149026","article-title":"Epidermolysis bullosa hereditaria treated with antimalarials","volume":"84","author":"Baer","year":"1961","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.adengl.2012.10.021_bib0580","first-page":"122","article-title":"Dystrophic epydermolysis bullosa treated with chloroquine","volume":"79","author":"Dorsey","year":"1959","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.adengl.2012.10.021_bib0585","doi-asserted-by":"crossref","first-page":"4344","DOI":"10.1182\/blood.V86.11.4344.bloodjournal86114344","article-title":"Chloroquine treatment affects T-cell priming to minor histocompatibility antigens and graft-versus-host disease","volume":"86","author":"Schultz","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.adengl.2012.10.021_bib0590","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1111\/j.1365-2133.1995.tb08725.x","article-title":"Hydroxychloroquine in the treatment of chronic erythema nodosum","volume":"132","author":"Alloway","year":"1995","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.adengl.2012.10.021_bib0595","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1016\/S0190-9622(08)80923-1","article-title":"Corticosteroid-sparing effect of hydroxychloroquine in a patient with early-onset Weber-Christian syndrome","volume":"23","author":"Sorensen","year":"1990","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.adengl.2012.10.021_bib0600","first-page":"1866","article-title":"An ophthalmological view on the efficacy and safety of chloroquine versus hydroxychloroquine","volume":"26","author":"Easterbrook","year":"1999","journal-title":"J Rheumatol"},{"key":"10.1016\/j.adengl.2012.10.021_bib0605","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.ophtha.2010.11.017","article-title":"Revised recommendations on screening for chloroquine and hydroxychloroquine retinopathy","volume":"118","author":"Marmor","year":"2011","journal-title":"Ophthalmology"},{"key":"10.1016\/j.adengl.2012.10.021_bib0610","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1002\/acr.20133","article-title":"Rates and predictors of hydroxychloroquine retinal toxicity in patients with rheumatoid arthritis and systemic lupus erythematosus","volume":"62","author":"Wolfe","year":"2010","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.adengl.2012.10.021_bib0615","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1016\/S0161-6420(02)01168-5","article-title":"Recommendations on screening for chloroquine and hydroxychloroquine retinopathy: a report by the American Academy of Ophthalmology","volume":"109","author":"Marmor","year":"2002","journal-title":"Ophthalmology"},{"key":"10.1016\/j.adengl.2012.10.021_bib0620","first-page":"380","article-title":"Long-term use of antimalarial drugs in rheumatic diseases","volume":"30","author":"Jover","year":"2012","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.adengl.2012.10.021_bib0625","first-page":"552","article-title":"Chloroquine-induced achromotrichia. An ultrastructural study","volume":"124","author":"Asch","year":"1997","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.adengl.2012.10.021_bib0630","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/S0190-9622(85)70109-0","article-title":"Toxic psychosis: a complication of antimalarial therapy","volume":"12","author":"Ward","year":"1985","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.adengl.2012.10.021_bib0635","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1001\/archderm.1984.01650420075020","article-title":"Antimalarial psychosis revisited","volume":"120","author":"Evans","year":"1984","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.adengl.2012.10.021_bib0640","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s00296-003-0435-8","article-title":"Seizure associated with chloroquine therapy in a patient with systemic lupus erythematosus","volume":"24","author":"Tristano","year":"2004","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.adengl.2012.10.021_bib0645","first-page":"808","article-title":"Discontinuation of antimalarial drugs in systemic lupus erythematosus","volume":"26","author":"Wang","year":"1999","journal-title":"J Rheumatol"},{"key":"10.1016\/j.adengl.2012.10.021_bib0650","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1136\/hrt.81.2.221","article-title":"Chloroquine cardiomyopathy with conduction disorders","volume":"81","author":"Baguet","year":"1999","journal-title":"Heart"},{"key":"10.1016\/j.adengl.2012.10.021_bib0655","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1093\/rheumatology\/kel402","article-title":"Heart conduction disorders related to antimalarials toxicity: an analysis of electrocardiograms in 85 patients treated with hydroxychloroquine for connective tissue diseases","volume":"46","author":"Costedoat-Chalumeau","year":"2007","journal-title":"Rheumatology"},{"key":"10.1016\/j.adengl.2012.10.021_bib0660","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1191\/0961203306lu2345oa","article-title":"The cardiac safety of chloroquine phosphate treatment in patients with systemic lupus erythematosus: the influence on arrhythmia, heart rate variability and repolarization parameters","volume":"15","author":"Wozniacka","year":"2006","journal-title":"Lupus"},{"key":"10.1016\/j.adengl.2012.10.021_bib0665","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00128071-200506010-00001","article-title":"Optimal use of antimalarials in treating cutaneous lupus erythematosus","volume":"6","author":"Wozniacka","year":"2005","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.adengl.2012.10.021_bib0670","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1002\/art.10150","article-title":"Evidence of transplacental passage of hydroxychloroquine in humans","volume":"46","author":"Costedoat-Chalumeau","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.adengl.2012.10.021_bib0675","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1055\/s-2007-999371","article-title":"Pregnancy outcome following first trimester exposure to chloroquine","volume":"8","author":"Levy","year":"1991","journal-title":"Am J Perinatol"},{"key":"10.1016\/j.adengl.2012.10.021_bib0680","first-page":"1715","article-title":"Hydroxychloroquine in pregnant patients with systemic lupus erythematosus","volume":"23","author":"Parke","year":"1996","journal-title":"J Rheumatol"},{"key":"10.1016\/j.adengl.2012.10.021_bib0685","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1136\/ard.55.7.486","article-title":"Hydroxychloroquine and lupus pregnancy: review of a series of 36 cases","volume":"55","author":"Buchanan","year":"1996","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.adengl.2012.10.021_bib0690","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S0140-6736(01)06004-4","article-title":"Ocular toxicity and antenatal exposure to chloroquine or hydroxychloroquine for rheumatic diseases","volume":"358","author":"Klinger","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.adengl.2012.10.021_bib0695","doi-asserted-by":"crossref","first-page":"3207","DOI":"10.1002\/art.11304","article-title":"Safety of hydroxychloroquine in pregnant patients with connective tissue diseases: a study of one hundred thirty-three cases compared with a control group","volume":"48","author":"Costedoat-Chalumeau","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.adengl.2012.10.021_bib0700","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1191\/0961203304lu528oa","article-title":"Chloroquine gestational use in systemic lupus erythematosus: assessing the risk of child ototoxicity by pure tone audiometry","volume":"13","author":"Borba","year":"2004","journal-title":"Lupus"},{"key":"10.1016\/j.adengl.2012.10.021_bib0705","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/sj.jp.7211208","article-title":"Follow-up of infants exposed to hydroxychloroquine given to mothers during pregnancy and lactation","volume":"25","author":"Motta","year":"2005","journal-title":"J Perinatol"}],"container-title":["Actas Dermo-Sifiliogr\u00e1ficas (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1578219014000377?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1578219014000377?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T03:52:50Z","timestamp":1761623570000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1578219014000377"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4]]},"references-count":141,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,4]]}},"alternative-id":["S1578219014000377"],"URL":"https:\/\/doi.org\/10.1016\/j.adengl.2012.10.021","relation":{},"ISSN":["1578-2190"],"issn-type":[{"value":"1578-2190","type":"print"}],"subject":[],"published":{"date-parts":[[2014,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antimalarials in Dermatology: Mechanism of Action, Indications, and Side Effects","name":"articletitle","label":"Article Title"},{"value":"Actas Dermo-Sifiliogr\u00e1ficas (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.adengl.2012.10.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.ad.2012.10.005","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Espa\u00f1a, S.L. and AEDV. All rights reserved.","name":"copyright","label":"Copyright"}]}}